Your browser doesn't support javascript.
loading
The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity.
Ho, Patricia; Melms, Johannes C; Rogava, Meri; Frangieh, Chris J; Pozniak, Joanna; Shah, Shivem B; Walsh, Zachary; Kyrysyuk, Oleksandr; Amin, Amit Dipak; Caprio, Lindsay; Fullerton, Benjamin T; Soni, Rajesh Kumar; Ager, Casey R; Biermann, Jana; Wang, Yiping; Khosravi-Maharlooei, Mohsen; Zanetti, Giorgia; Mu, Michael; Fatima, Hijab; Moore, Emily K; Vasan, Neil; Bakhoum, Samuel F; Reiner, Steven L; Bernatchez, Chantale; Sykes, Megan; Mace, Emily M; Wucherpfennig, Kai W; Schadendorf, Dirk; Bechter, Oliver; Shah, Parin; Schwartz, Gary K; Marine, Jean-Christophe; Izar, Benjamin.
Affiliation
  • Ho P; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Melms JC; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Rogava M; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Frangieh CJ; Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Klarman Cell Observatory, the Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Pozniak J; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, 3000 Leuven, Belgium; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.
  • Shah SB; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Walsh Z; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Kyrysyuk O; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Amin AD; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Caprio L; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Fullerton BT; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA.
  • Soni RK; Proteomics and Macromolecular Crystallography Shared Resource, Columbia University, New York, NY 10032, USA.
  • Ager CR; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Biermann J; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA; Program for Mathematical Genomics, Department of Systems Biology, Columbia Un
  • Wang Y; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA; Program for Mathematical Genomics, Department of Systems Biology, Columbia Un
  • Khosravi-Maharlooei M; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA; Department of Immunology, Mayo Clinic, Scottsdale, AZ 85259, USA.
  • Zanetti G; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Mu M; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA.
  • Fatima H; Department of Pediatrics, Columbia University, New York, NY 10032, USA.
  • Moore EK; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA; Department of Medicine, Division of Rheumatology, Columbia University, New York, NY 10032, USA.
  • Vasan N; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.
  • Bakhoum SF; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Reiner SL; Department of Pediatrics, Columbia University, New York, NY 10032, USA; Department of Microbiology and Immunology, Columbia University, New York, NY 10032, USA.
  • Bernatchez C; Department of Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Sykes M; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA; Department of Microbiology and Immunology, Columbia University, New York, NY 10032, USA; Department of Surgery, Columbia University, New York, NY 10032, USA.
  • Mace EM; Department of Pediatrics, Columbia University, New York, NY 10032, USA.
  • Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Schadendorf D; Department of Dermatology, University Hospital Essen and German Cancer Consortium, Partner Site, 45147 Essen, Germany.
  • Bechter O; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.
  • Shah P; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA.
  • Schwartz GK; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.
  • Marine JC; Laboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, 3000 Leuven, Belgium; Department of Oncology, KU Leuven, 3000 Leuven, Belgium.
  • Izar B; Department of Medicine, Division of Hematology and Oncology, Columbia University, New York, NY 10032, USA; Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY 10032, USA; Program for Mathematical Genomics, Department of Systems Biology, Columbia Un
Cancer Cell ; 41(7): 1207-1221.e12, 2023 07 10.
Article in En | MEDLINE | ID: mdl-37327789
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Melanoma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Melanoma Type of study: Prognostic_studies Limits: Animals Language: En Journal: Cancer Cell Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: